TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells.
Biochem Pharmacol
; 124: 19-28, 2017 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-27810320
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenanthrenes
/
Retinoid X Receptor alpha
/
Diterpenes
Limits:
Humans
Language:
En
Journal:
Biochem Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
China